Adverum Biotechnologies
ADVM
ADVM
60 hedge funds and large institutions have $52.2M invested in Adverum Biotechnologies in 2023 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 14 increasing their positions, 15 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
7% less repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 15
47% less capital invested
Capital invested by funds: $97.9M → $52.2M (-$45.8M)
Holders
60
Holding in Top 10
2
Calls
$42K
Puts
$3K
Top Buyers
| 1 | +$2.5M | |
| 2 | +$1.39M | |
| 3 | +$481K | |
| 4 |
Renaissance Technologies
New York
|
+$412K |
| 5 |
WVP
Worth Venture Partners
Fort Lee,
New Jersey
|
+$341K |
Top Sellers
| 1 | -$1.07M | |
| 2 | -$715K | |
| 3 | -$427K | |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$356K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$353K |